Published Reports and News
News and Reports
Key Findings from Published Reports
- 32% reduction in overall Bloodstream Infection (BSI) Rates
- 54% reduction in vascular Access-Related Bloodstream Infection (ARBSI) Rates
- 22% reduction in CVC-BSI rates at 3 months; 41% reduction at 1 year
- 27% reduction in hospitalizations due to Sepsis at 1 year
- Decrease in unadjusted pooled mean Bloodstream Infection (BSI) Rates and Access-Related Bloodstream Infection (ARBSI) rates between baseline and intervention periods
- No increase in infection rates over 48-month period
Reports from the CDC Collaborative.
- Yi SH, Kallen AJ, Hess S, Bren VR, Lincoln ME, Downham G, Kelley K, Booth SL, Weirich H, Shugart A, Lines C, Melville A, Jernigan JA, Kleinbaum DG, Patel PR. (2016) Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort. Infect Control Hosp Epidemiol, 2016;1-4
- Patel, P.R., Yi, S.H., Booth, S., Bren, V., Downham, G., Hess, S., … Kallen, A.J. (2013). Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report. American Journal of Kidney Diseases, 62(2), 322-330.
- Lindberg, C., Downham, G., Buscell, P., Jones, E., Peterson, P., & Krebs, V. (2013). Embracing collaboration: A novel strategy for reducing bloodstream infections in outpatient hemodialysis centers. American Journal of Infection Control, 41(6), 513-519.
- Hess, S., Alston; W.K., Bushey, M.; Rimmer, J. (October, 2012). A four year experience with a central line access-related bloodstream infection (CL-ARB) prevention program in six outpatient hemodialysis (HD) centers. Oral abstract presented at IDWeek 2012. San Diego, CA.
- Yi, S.H., Kallen, A.J., Jernigan, J.A., & Patel, P.R. (May, 2012). Reduction in bloodstream infection rates in outpatient hemodialysis centers participating in a CDC prevention collaborative. Poster presented at the National Kidney Foundation Spring Clinical Meetings 2012. Washington, DC.
- Centers for Disease Control and Prevention (CDC). (2012). Reducing bloodstream infections in an outpatient hemodialysis center. Morbidity and Mortality Weekly Report, 16(61), 169-173.
- Kallen, A.J., Patel, P.R., Hess, S. (2011). Intolerance of chlorhexidine as a skin antiseptic in patients undergoing hemodialysis. Infection Control and Hospital Epidemiology, 32(11), 1144-1146.
- Lincoln, M. (2011). Preventing catheter-associated bloodstream infections in hemodialysis centers: The facility perspective. Nephrology Nursing Journal, 38(5), 411-415.
Other Published Reports
News from websites and organizations with a focus on dialysis.
- See, I., Shugart, A., Lamb, C., Kallen, A.J., Patel, P.R., Sinkowitz-Cochran, R.L. (2014). Infection control and bloodstream infection prevention: the perspective of patients receiving hemodialysis. Nephrology Nursing Journal, 41(1), 37-39.
- CDC Vital Signs Report: Making Health Care Safer Reducing Bloodstream Infections [PDF – 2.44 MB]
- Vital Signs: Central Line–Associated Blood Stream Infections — United States, 2001, 2008, and 2009 MMWR March 4, 2011 / 60(08);243-248
- Invasive Methicillin-resistant Staphylococcus aureus Infections Among Dialysis Patients, United States, 2005 MMWR March 9, 2007;56(09);197-199
- Page last reviewed: October 30, 2017
- Page last updated: October 30, 2017
- Content source: